Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
With a market cap of 24.65B, Incyte(INCY) trades at $120.02. The stock has a price-to-earnings ratio of 64.37.
During the trading session on 2026-11-14, Incyte(INCY) shares reached a daily high of $122.07 and a low of $119.72. At a current price of $120.02, the stock is +0.2% higher than the low and still -1.7% under the high.
Trading activity shows a volume of 950.49K, compared to an average daily volume of 1.52M.
Over the past 52 weeks, Incyte(INCY) stock has traded between a high of $132.60 and a low of $89.25.
Over the past 52 weeks, Incyte(INCY) stock has traded between a high of $132.60 and a low of $89.25.
INCY News
...
Incyte ( (INCY) ) has shared an announcement. Incyte Corporation is developing INCB123667, a selective CDK2 inhibitor, for ovarian cancer. The company decided...
Incyte (INCY) has decided not to proceed with the planned Phase 3 MAESTRA-3 study evaluating INCB123667, the company’s selective CDK2 inhibitor, in combination...
Analyst ratings
54%
of 28 ratingsMore INCY News
Incyte (INCY) just paired its push beyond JAKAFI with fresh news in colorectal cancer. A new phase II collaboration with Natera centers on INCA33890 and MRD-gui...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.